A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.
about
Review of pharmacological treatment in mood disorders and future directions for drug development.Predictive animal models of mania: hits, misses and future directions.Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients.Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approachRequirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.Protein kinase C, an elusive therapeutic target?New drugs for bipolar disorder.Contributions of animal models to the study of mood disorders.Tamoxifen use for the management of mania: a review of current preclinical evidence.Polyphenol compounds and PKC signaling.Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine.Inositol depletion, GSK3 inhibition and bipolar disorder.Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania.Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania.Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
P2860
Q26853509-4AE7069B-E40C-4EDE-8774-D7B8B2437CCFQ30462823-C69398E1-F97F-4226-B8DC-4897814E4818Q34026112-BE432DA4-2D14-495B-8B34-CA88E77DFEADQ34268501-DFBF6C0C-A612-4162-8938-314773F2BED9Q35785604-AD170A83-83B0-4D80-837B-D359E61DF2D9Q37141320-3EEB44A2-2D78-4B01-A2A1-60563794076EQ37923845-96E847F8-6608-46AF-BDF2-4A0206643912Q38165755-90D11B99-D37C-4F9E-ABBB-C0C7CB049684Q38179926-43961EB6-76F5-4050-8705-1F8821C506F1Q38846159-DA92AA0A-532B-4748-9109-CFA1C6D8E046Q47109377-0373F8D5-5525-48CD-AF13-96683770EE51Q47975522-EF2E956C-38BA-47CE-80FA-F0829E3504F9Q48056810-26377619-1C75-41B4-BBEF-0ABDF6A7B1A1Q48331624-002C3199-17E4-4FE2-93A9-C9C9EE10A22AQ48579986-F1C61444-47F3-40F5-920C-0321BA0FCA23Q53495664-37F6D8C7-CAC3-4236-BDA6-C2E078D9D149
P2860
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of the preclinical an ...... elopment for bipolar disorder.
@en
A review of the preclinical an ...... elopment for bipolar disorder.
@nl
type
label
A review of the preclinical an ...... elopment for bipolar disorder.
@en
A review of the preclinical an ...... elopment for bipolar disorder.
@nl
prefLabel
A review of the preclinical an ...... elopment for bipolar disorder.
@en
A review of the preclinical an ...... elopment for bipolar disorder.
@nl
P2860
P1476
A review of the preclinical an ...... elopment for bipolar disorder.
@en
P2093
Carlos A Zarate
Nancy DiazGranados
P2860
P2888
P304
P356
10.1007/S11920-008-0081-7
P407
P577
2008-12-01T00:00:00Z